The Mediating Role of Systemic Inflammation and Moderating Role of Racialization in Disparities in Incident Dementia

Overview

Journal Commun Med (Lond)

Publisher Nature Portfolio

Specialty General Medicine

Date 2024 Jul 13

PMID 39003383

Authors

Cesar Higgins Tejera

Erin B Ware

Margaret T Hicken

Lindsay C Kobayashi

Herong Wang

Freida Blostein

Matthew Zawistowski

Bhramar Mukherjee

Kelly M Bakulski

Affiliations

Soon will be listed here.

Abstract

Background: Exposure to systemic racism is linked to increased dementia burden. To assess systemic inflammation as a potential pathway linking exposure to racism and dementia disparities, we investigated the mediating role of C-reactive protein (CRP), a systemic inflammation marker, and the moderating role of the racialization process in incident dementia.

Methods: In the US Health and Retirement Study (n = 6,908), serum CRP was measured at baseline (2006, 2008 waves). Incident dementia was classified by cognitive tests over a six-year follow-up. Self-reported racialized categories were a proxy for exposure to the racialization process. We decomposed racialized disparities in dementia incidence (non-Hispanic Black and/or Hispanic vs. non-Hispanic white) into 1) the mediated effect of CRP, 2) the moderated portion attributable to the interaction between racialized group membership and CRP, and 3) the controlled direct effect (other pathways through which racism operates).

Results: The 6-year cumulative incidence of dementia is 12%. Among minoritized participants (i.e., non-Hispanic Black and/or Hispanic), high CRP levels ( ≥ 75 percentile or 4.73μg/mL) are associated with 1.26 (95%CI: 0.98, 1.62) times greater risk of incident dementia than low CRP ( < 4.73μg/mL). Decomposition analysis comparing minoritized versus non-Hispanic white participants shows that the mediating effect of CRP accounts for 3% (95% CI: 0%, 6%) of the racial disparity, while the interaction effect between minoritized group status and high CRP accounts for 14% (95% CI: 1%, 27%) of the disparity. Findings are robust to potential violations of causal mediation assumptions.

Conclusions: Minoritized group membership modifies the relationship between systemic inflammation and incident dementia.

References

Almeida J, Biello K, Pedraza F, Wintner S, Viruell-Fuentes E . The association between anti-immigrant policies and perceived discrimination among Latinos in the US: A multilevel analysis. SSM Popul Health. 2018; 2:897-903. PMC: 5757908. DOI: 10.1016/j.ssmph.2016.11.003. View

Wyss-Coray T . Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006; 12(9):1005-15. DOI: 10.1038/nm1484. View

Dransfield M, Bailey W . COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med. 2006; 27(3):463-71, vii. DOI: 10.1016/j.ccm.2006.04.005. View

Goosby B, Cheadle J, Mitchell C . Stress-Related Biosocial Mechanisms of Discrimination and African American Health Inequities. Annu Rev Sociol. 2023; 44(1):319-340. PMC: 10704394. DOI: 10.1146/annurev-soc-060116-053403. View

Weinberg C . How bad is categorization?. Epidemiology. 1995; 6(4):345-7. View

Rohleder N . Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med. 2014; 76(3):181-9. DOI: 10.1097/PSY.0000000000000049. View

Hobson J, Moody M, Sorge R, Goodin B . The neurobiology of social stress resulting from Racism: Implications for pain disparities among racialized minorities. Neurobiol Pain. 2022; 12:100101. PMC: 9449662. DOI: 10.1016/j.ynpai.2022.100101. View

Howe C, Bailey Z, Raifman J, Jackson J . Recommendations for Using Causal Diagrams to Study Racial Health Disparities. Am J Epidemiol. 2022; 191(12):1981-1989. PMC: 10144617. DOI: 10.1093/aje/kwac140. View

Hegazy S, Thomassen J, Rasmussen I, Nordestgaard B, Tybjaerg-Hansen A, Frikke-Schmidt R . C-reactive protein levels and risk of dementia-Observational and genetic studies of 111,242 individuals from the general population. Alzheimers Dement. 2022; 18(11):2262-2271. PMC: 9790296. DOI: 10.1002/alz.12568. View

10.

Agorastos A, Chrousos G . The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry. 2021; 27(1):502-513. DOI: 10.1038/s41380-021-01224-9. View

11.

Fan Y, Chou C, Bintoro B, Chien K, Bai C . High sensitivity C-reactive protein and glycated hemoglobin levels as dominant predictors of all-cause dementia: a nationwide population-based cohort study. Immun Ageing. 2022; 19(1):10. PMC: 8849019. DOI: 10.1186/s12979-022-00265-0. View

12.

de Craen A, Gussekloo J, Vrijsen B, Westendorp R . Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol. 2005; 161(2):114-20. DOI: 10.1093/aje/kwi029. View

13.

Asad A, Clair M . Racialized legal status as a social determinant of health. Soc Sci Med. 2017; 199:19-28. DOI: 10.1016/j.socscimed.2017.03.010. View

14.

Zilioli S, Gomez J, Jiang Y, Rodriguez-Stanley J . Childhood Socioeconomic Status and Cardiometabolic Health: A Test of the John Henryism Hypothesis in African American Older Adults. J Gerontol A Biol Sci Med Sci. 2021; 77(2):e56-e64. PMC: 8824633. DOI: 10.1093/gerona/glab280. View

15.

Cha H, Farina M, Hayward M . Socioeconomic status across the life course and dementia-status life expectancy among older Americans. SSM Popul Health. 2021; 15:100921. PMC: 8452881. DOI: 10.1016/j.ssmph.2021.100921. View

16.

Coccaro E, Lee R, Coussons-Read M . Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study. J Neural Transm (Vienna). 2014; 122(2):321-6. PMC: 4898482. DOI: 10.1007/s00702-014-1263-6. View

17.

Crimmins E, Kim J, McCreath H, Faul J, Weir D, Seeman T . Validation of blood-based assays using dried blood spots for use in large population studies. Biodemography Soc Biol. 2014; 60(1):38-48. PMC: 4117354. DOI: 10.1080/19485565.2014.901885. View

18.

Adkins-Jackson P, Weuve J . Racially Segregated Schooling and the Cognitive Health of Black Adults in the United States-Why It Matters. JAMA Netw Open. 2021; 4(10):e2130448. DOI: 10.1001/jamanetworkopen.2021.30448. View

19.

Krieger N . Measures of Racism, Sexism, Heterosexism, and Gender Binarism for Health Equity Research: From Structural Injustice to Embodied Harm-An Ecosocial Analysis. Annu Rev Public Health. 2019; 41:37-62. DOI: 10.1146/annurev-publhealth-040119-094017. View

20.

Tang M, Stern Y, Marder K, Bell K, Gurland B, Lantigua R . The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998; 279(10):751-5. DOI: 10.1001/jama.279.10.751. View